$111.92
-0.75-0.67%
al cierre: Nov 19, 4:00 PM EST
$111.92
N/A
After hour: 4:00 PM EST
Comments
Loading...
Encompass Health Actividad de operaciones con información privilegiada
EHCNYSE
Actividad de operaciones de insiders
Sigue la actividad de operaciones con información privilegiada más reciente de Encompass Health. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Encompass Health.
¿Qué es la actividad interna?
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
¿Qué están haciendo Encompass Health Corp los iniciados?
Los expertos no han informado de compras ni ventas en los últimos 30 días.
Compras y ventas recientes notables de información privilegiada
- El agosto 27, 2025, Patrick W. Tuer, la empresa EVP, CHIEF OPERATING OFFICER sold 1.02K acciones por $123.59 cada una.
Estadísticas de propiedad de Encompass Health Corp
Acciones en circulación
100.900M
Acciones en manos de personas con información privilegiada
5.656M
Porcentaje de acciones en manos de personas con información privilegiada
5.62%
Acciones en manos de instituciones
74.870M
Porcentaje de acciones en manos de instituciones
74.4%
Aug 27, 2025 | EVP, CHIEF OPERATING OFFICER | -1.02K | $123.59 | -$126.06K | SELL | -5.13% | 18.85K | Aug 27 | ||
May 20, 2025 | PRESIDENT & CEO | 0.00 | $80.81 | -$9.64M | SELL-OPTIONS | 0.00% | 527.07K | May 20 | ||
May 07, 2025 | CHIEF MEDICAL OFFICER | -4.28K | $116.61 | -$498.97K | SELL | -26.35% | 11.96K | May 06 | ||
Apr 30, 2025 | EVP, GEN COUNSEL & SECRETARY | 0.00 | $74.93 | -$797.30K | SELL-OPTIONS | 0.00% | 79.71K | Apr 29 | ||
Apr 30, 2025 | EVP & CHIEF FINANCIAL OFFICER | 0.00 | $73.33 | -$3.64M | SELL-OPTIONS | 0.00% | 125.56K | Apr 29 | ||
Feb 13, 2025 | CHIEF ACCOUNTING OFFICER | -5.04K | $98.29 | -$495.58K | SELL | -6.79% | 69.16K | Feb 13 | ||
Aug 14, 2024 | EVP & CHIEF FINANCIAL OFFICER | 0.00 | $61.08 | -$619.20K | SELL-OPTIONS | 0.00% | 261.86K | Aug 13 | ||
May 24, 2024 | CHIEF MEDICAL OFFICER | -10.00K | $85.02 | -$850.20K | SELL | -34.97% | 18.59K | May 24 | ||
May 07, 2024 | EVP, GEN COUNSEL & SECRETARY | 0.00 | $56.50 | -$798.12K | SELL-OPTIONS | 0.00% | 84.77K | May 06 | ||
May 07, 2024 | DIRECTOR | 2.00K | $83.73 | $167.46K | BUY | 13.29% | 17.05K | May 03 | ||
May 01, 2024 | PRESIDENT & CEO | 0.00 | $57.63 | -$2.31M | SELL-OPTIONS | 0.00% | 554.10K | Apr 30 | ||
Nov 14, 2023 | EVP & CHIEF FINANCIAL OFFICER | 5.41K | $44.97 | -$269.58K | SELL-OPTIONS | 2.29% | 241.92K | Nov 13 | ||
Aug 18, 2023 | CHIEF MEDICAL OFFICER | -8.29K | $69.58 | -$577.10K | SELL | -26.44% | 23.08K | Aug 17 | ||
Aug 17, 2023 | PRESIDENT & CEO | 0.00 | $48.80 | -$1.13M | SELL-OPTIONS | 0.00% | 497.40K | Aug 16 | ||
Feb 13, 2023 | EVP & CHIEF FINANCIAL OFFICER | 0.00 | $40.43 | -$728.51K | SELL-OPTIONS | 0.00% | 178.73K | Feb 10 | ||
Nov 01, 2022 | DIRECTOR | 1.83K | $54.67 | $100.05K | BUY | 21.00% | 10.55K | Oct 31 | ||
Aug 19, 2022 | PRESIDENT & CEO | 0.00 | $36.66 | -$678.50K | SELL-OPTIONS | 0.00% | 440.89K | Aug 17 | ||
May 09, 2022 | DIRECTOR | 3.23K | $66.48 | $66.48K | BUY | 1536.19% | 3.44K | May 05 - May 06 | ||
Dec 02, 2021 | DIRECTOR | 354.00 | $56.61 | $20.04K | BUY | 7.22% | 5.26K | Dec 02 | ||
Mar 09, 2021 | CHIEF ACCOUNTING OFFICER | -8.59K | $81.40 | -$699.14K | SELL | -11.89% | 63.64K | Mar 08 | ||
Nov 19, 2020 | — | -6.65K | $75.22 | -$500.21K | SELL | -24.85% | 20.11K | Nov 17 | ||
May 29, 2020 | — | 0.00 | $49.97 | -$1.21M | OPTION EXERCISE | 0.00% | 157.27K | May 28 | ||
May 18, 2020 | — | -2.50K | $64.73 | -$161.82K | SELL | -5.29% | 44.76K | May 15 | ||
May 14, 2020 | — | 0.00 | $41.47 | -$1.07M | OPTION EXERCISE | 0.00% | 383.06K | May 14 | ||
Mar 16, 2020 | — | -2.00K | $59.04 | -$118.08K | SELL | -2.76% | 70.57K | Mar 12 | ||
Mar 13, 2020 | — | 125.00K | $58.69 | $7.34M | PURCHASE | 187.29% | 191.74K | Mar 12 | ||
Mar 13, 2020 | — | 1.00K | $64.07 | $64.07K | PURCHASE | 1.37% | 73.74K | Mar 11 | ||
Mar 12, 2020 | — | 40.00K | $64.24 | $2.57M | PURCHASE | 149.59% | 66.74K | Mar 11 | ||
Nov 06, 2019 | DIRECTOR | 500.00 | $69.19 | $34.59K | BUY | 0.70% | 71.56K | Nov 05 | ||
May 03, 2019 | PRESIDENT & CEO | 0.00 | $41.45 | -$2.98M | SELL-OPTIONS | 0.00% | 342.38K | May 01 | ||
Mar 08, 2019 | DIRECTOR | 1.00K | $58.84 | $58.84K | BUY | 1.46% | 69.28K | Mar 07 | ||
Aug 14, 2018 | CHIEF ACCOUNTING OFFICER | -9.46K | $80.04 | -$756.94K | SELL | -12.70% | 65.01K | Aug 14 | ||
Aug 06, 2018 | CHIEF HUMAN RESOURCES OFFICER | -28.95K | $78.00 | -$2.26M | SELL | -42.26% | 39.57K | Aug 03 | ||
May 15, 2018 | PRESIDENT, INPATIENT HOSPITALS | -1.80K | $62.73 | -$112.79K | SELL | -5.28% | 32.27K | May 14 | ||
May 11, 2018 | CHIEF HUMAN RESOURCES OFFICER | -30.98K | $63.00 | -$1.95M | SELL | -31.14% | 68.52K | May 09 | ||
May 03, 2018 | PRESIDENT, INPATIENT HOSPITALS | 0.00 | $52.36 | -$79.07K | SELL-OPTIONS | 0.00% | 34.07K | May 02 | ||
May 02, 2018 | PRESIDENT & CEO | 0.00 | $34.41 | -$1.76M | SELL-OPTIONS | 0.00% | 291.96K | May 01 |
PREGUNTAS FRECUENTES
¿Es legal el uso de información privilegiada?
Las operaciones con información privilegiada son legales siempre que se notifiquen a la Comisión de Bolsa y Valores (SEC). El comercio ilegal de valores se produce cuando la persona con información privilegiada viola un deber fiduciario o no informa de sus operaciones.
¿Cuáles son algunos ejemplos de manipulación del mercado?
Las operaciones con información privilegiada, los esquemas de pump and dump, el front running y las operaciones de lavado son ejemplos de manipulación del mercado. Los inversores que siguen el movimiento de activos con información privilegiada deben pensar atentamente por qué estos operadores con información privilegiada están negociando sus acciones antes de seguir adelante.
Explora operaciones con información privilegiada sobre todos los valores.